Reaction Details Report a problem with these data
Target
cAMP-specific 3',5'-cyclic phosphodiesterase 4D [538-740]
Ligand
BDBM547787
Substrate
n/a
Meas. Tech.
PDE4 Assay
IC50
<10±n/a nM
Citation
 Andrews, M; Greve, DR; Larsen, J Substituted azetidine dihydrothienopyrimidines and their use as phosphodiesterase inhibitors US Patent  US11292799 Publication Date 4/5/2022 
Target
Name:
cAMP-specific 3',5'-cyclic phosphodiesterase 4D [538-740]
Synonyms:
DPDE3 | PDE4D | PDE4D_HUMAN
Type:
Protein
Mol. Mass.:
23661.98
Organism:
Homo sapiens (Human)
Description:
Q08499[538-740]
Residue:
203
Sequence:
VGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTL
  
Inhibitor
Name:
BDBM547787
Synonyms:
(5R)—N-(1,1-Dioxothian-4-yl)-5-oxido-2-(3-phenylazetidin-1-yl)-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl-amine | US11292799, Example 17
Type:
Small organic molecule
Emp. Form.:
C20H24N4O3S2
Mol. Mass.:
432.56
SMILES:
[O-][S@@+]1CCc2nc(nc(NC3CCS(=O)(=O)CC3)c12)N1CC(C1)c1ccccc1 |r|
Structure:
Search PDB for entries with ligand similarity: